Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 37, Issue 6, Pages 435-453Publisher
WILEY
DOI: 10.1111/j.1365-2362.2007.01807.x
Keywords
criteria; mastocytosis; patient selection; standardization; targeted drugs
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000249, ZIAAI000249] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Although a classification for mastocytosis and diagnostic criteria are available, there remains a need to define standards for the application of diagnostic tests, clinical evaluations, and treatment responses. To address these demands, leading experts discussed current issues and standards in mastocytosis in a Working Conference. The present article provides the resulting outcome with consensus statements, which focus on the appropriate application of clinical and laboratory tests, patient selection for interventional therapy, and the selection of appropriate drugs. In addition, treatment response criteria for the various clinical conditions, disease-specific symptoms, and specific pathologies are provided. Resulting recommendations and algorithms should greatly facilitate the management of patients with mastocytosis in clinical practice, selection of patients for therapies, and the conduct of clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available